Postoperative use of aprotinin in cardiac operations: An alternative to its prophylactic use Sertaç Ciçek, MD*, Ufuk Demirkiliç, MD, Ertugrul Özal, MD, Erkan Kuralay, MD, Hakan Bingol, MD, Harun Tatar, MD, Ömer Y. Özturk, MD The Journal of Thoracic and Cardiovascular Surgery Volume 112, Issue 6, Pages 1462-1467 (December 1996) DOI: 10.1016/S0022-5223(96)70004-1 Copyright © 1996 Mosby, Inc. Terms and Conditions
Fig. 1 A, Hourly blood loss for the first 6 hours after the initiation of aprotinin or placebo. Values are shown as mean ± standard error of the mean. B, Cumulative blood loss in the first 6 hours. The Journal of Thoracic and Cardiovascular Surgery 1996 112, 1462-1467DOI: (10.1016/S0022-5223(96)70004-1) Copyright © 1996 Mosby, Inc. Terms and Conditions
Fig. 1 A, Hourly blood loss for the first 6 hours after the initiation of aprotinin or placebo. Values are shown as mean ± standard error of the mean. B, Cumulative blood loss in the first 6 hours. The Journal of Thoracic and Cardiovascular Surgery 1996 112, 1462-1467DOI: (10.1016/S0022-5223(96)70004-1) Copyright © 1996 Mosby, Inc. Terms and Conditions